Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

539 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Group B streptococcal infections.
Baker CJ. Baker CJ. Clin Perinatol. 1997 Mar;24(1):59-70. Clin Perinatol. 1997. PMID: 9099502 Review.
Resource utilization associated with initial hospital stays complicated by early onset group B streptococcal disease.
Platt R, Adelson-Mitty J, Weissman L, Zaleznik D, Lee ML, Baker CJ. Platt R, et al. Pediatr Infect Dis J. 1999 Jun;18(6):529-33. doi: 10.1097/00006454-199906000-00010. Pediatr Infect Dis J. 1999. PMID: 10391183
Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines.
Paoletti LC, Rench MA, Kasper DL, Molrine D, Ambrosino D, Baker CJ. Paoletti LC, et al. Infect Immun. 2001 Nov;69(11):6696-701. doi: 10.1128/IAI.69.11.6696-6701.2001. Infect Immun. 2001. PMID: 11598040 Free PMC article. Clinical Trial.
Group B streptococcal conjugate vaccines.
Baker CJ, Edwards MS. Baker CJ, et al. Arch Dis Child. 2003 May;88(5):375-8. doi: 10.1136/adc.88.5.375. Arch Dis Child. 2003. PMID: 12716700 Free PMC article. Review.
Recurrent group B streptococcal disease in infants: Who should receive rifampin?
Atkins JT, Heresi GP, Coque TM, Baker CJ. Atkins JT, et al. J Pediatr. 1998 Mar;132(3 Pt 1):537-9. doi: 10.1016/s0022-3476(98)70037-x. J Pediatr. 1998. PMID: 9544918
539 results
Jump to page
Feedback